TILRAY Aktie

 

Die neue Marke vereint bewährte Genetik, deutsches Anbauknow-how und strenge Qualitätsstandards, um Patienten und medizinisches Fachpersonal in ganz Deutschland zu unterstützen Die neue Marke vereint bewährte Genetik, deutsches Anbauknow-how und strenge Qualitätsstandards, um Patienten und medizinisches Fachpersonal in ganz Deutschland zu unterstützen...

24 American Craft Beer Favourites from Tilray, the 4th Largest Craft Brewer in the U.S., Including SweetWater, Montauk, 10 Barrel, Shock Top, Alpine, Green Flash, Blue Point and More... Debut at BrewDog Bars and Online 24 American Craft Beer Favourites from Tilray, the 4th Largest Craft Brewer in the U.S., Including SweetWater, Montauk, 10 Barrel, Shock Top, Alpine, Green Flash, Blue Point and More... Debut at BrewDog Bars and Online...

New Brand Combines Proven Genetics, German Cultivation Expertise, and Rigorous Quality Standards to Support Patients and Healthcare Professionals Across Germany New Brand Combines Proven Genetics, German Cultivation Expertise, and Rigorous Quality Standards to Support Patients and Healthcare Professionals Across Germany...

Tilray Brands, Inc. (TLRY) closed at $5.03 in the latest trading session, marking a +1.82% move from the prior day....

Most of Tilray's sales come from Canada and the European Union....

Tilray bought Brewdog on the cheap, but there's a reason why it got such a good price....

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $5.38, representing a -2% change from its previous close....

Don't hold your breath....

The bull case still hinges on legalization's progress....

Industry Leaders Convene on the Future of Medical Cannabis Regulation and Patient Access Industry Leaders Convene on the Future of Medical Cannabis Regulation and Patient Access...

Die Uhr tickt. Der Countdown läuft. Der Cannabis-Sektor steuert auf seine ultimative Entfesselung zu oder steuert direkt ins Chaos. Zwischen diesen beiden Extremen wird es sich wohl entscheiden. ...

Tilray's business has gotten bigger over the years, but it continues to struggle with achieving profitability....

International growth could make up for a lack of U.S. legalization progress...

Or is it just a value trap?...

Most regulatory headwinds remain for cannabis companies like Tilray....

Marijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon....

Tilray doesn't fit squarely into the value trap or value stock categories....

Tilray Brands eyes U.S. expansion as cannabis reclassification to Schedule III creates new opportunities for growth and clinical research. Importance Rank:  1 read more...

Zahlreiche Cannabis-Aktien legten am Mittwoch zweistellig zu. Der Kursschub ist dabei eng mit einem möglichen historischen Schritt der US-Regierung verknüpft....

Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation that the administration is preparing to reclassify marijuana to a less-dangerous drug category, a regulatory tailwind cannabis investors have been waiting on for ... Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation...